Diagnosis of Gastroesophageal Reflux Disease: Role of Endoscopy

  • A. Bansal
  • P. Sharma


Endoscopy is relatively insensitive for making the diagnosis of gastro esophageal reflux disease. However, the presence of erosive esophagitis and/or BE is highly suggestive of GERD. The presence of normal mucosa at endoscopy does not rule out the diagnosis of GERD. At present, the role of biopsies in these situations is unsettled and more data are needed. Newer endoscopic techniques such as chromoendoscopy, magnification and high resolution may demonstrate minimal changes in the distal squamous mucosa such as punctate erythema, pinpoint vessels etc. not seen by standard endoscopy. Some of these changes may respond to therapy with proton pump inhibitor. Endoscopy remains the best test to rule out complications of GERD and allows histological confirmation of esophageal pathology such as intestinal metaplasia, dysplasia and adenocarcinoma. Identifying the patient group with severe erosive esophagitis, BE and peptic strictures may help focus aggressive management that may potentially prevent future complications in these patient groups. Finally, endoscopy may be useful to rule out other diseases in the upper gastrointestinal tract.


Intestinal Metaplasia Erosive Esophagitis Eosinophilic Esophagitis Esophageal Acid Exposure Eosinophilic Gastroenteritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Kahrilas PJ (2003) Diagnosis of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 98: S15–S23PubMedCrossRefGoogle Scholar
  2. [2]
    Dent J, Brun J, Fendrick AM et al (1999) An evidencebased appraisal of reflux disease management — the genval workshop report. Gut 44(Suppl 2): 1–16CrossRefGoogle Scholar
  3. [3]
    Jian R, Galmiche JP, Bretagne JF (1999) Gastroesophageal reflux in adults: will a consensus be possible?. Gastroenterol Clin Biol 23: 1–2Google Scholar
  4. [4]
    Jones R (1995) Gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol (Suppl 211): 35–38Google Scholar
  5. [5]
    Kahrilas PJ, Quigley EM (1996) Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 110: 1982–1996PubMedCrossRefGoogle Scholar
  6. [6]
    Lind T, Havelund T, Carlsson R et al (1997) Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 32: 974–979PubMedCrossRefGoogle Scholar
  7. [7]
    Spechler SJ (1992) Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 51(Suppl 1): 24–29PubMedCrossRefGoogle Scholar
  8. [8]
    Hatlebakk JG, Berstad A, Carling L et al (1993) Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trial. Scand J Gastroenterol 28: 224–228PubMedGoogle Scholar
  9. [9]
    Hetzel DJ, Dent J, Reed WD et al (1988) Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 95: 903–912PubMedGoogle Scholar
  10. [10]
    Lundell LR, Dent J, Bennett JR et al (1999) Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 45: 172–180PubMedCrossRefGoogle Scholar
  11. [11]
    Ozzello L, Savary M, Roethlisberger B (1977) Columnar mucosa of the distal esophagus in patients with gastroesophageal reflux. Pathol Annu 12 (Pt 1): 41–86PubMedGoogle Scholar
  12. [12]
    Coenraad M, Masclee AA, Straathof JW et al (1998) Is Barrett’s esophagus characterized by more pronounced acid reflux than severe esophagitis? Am J Gastroenterol 93: 1068–1072PubMedCrossRefGoogle Scholar
  13. [13]
    Tefera L, Fein M, Ritter MP et al (1997) Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease? Am Surg 63: 933–936PubMedGoogle Scholar
  14. [14]
    Ghillebert G, Demeyere AM, Janssens J et al (1995) How well can quantitative 24-hour intraesophageal pH monitoring distinguish various degrees of reflux disease? Dig Dis Sci 40: 1317–1324PubMedCrossRefGoogle Scholar
  15. [15]
    Sanchez-Gey Venegas S, Yerro Paez VM, Pellicer Bautista FJ et al (1999) Relationship between endoscopic esophagitis and patterns of gastroesophageal reflux in ambulatory pHmetry. Rev Esp Enferm Dig 91: 125–132PubMedGoogle Scholar
  16. [16]
    Arango L, Angel A, Molina RI et al (2000) Comparison between digestive endoscopy and 24-hour esophageal pH monitoring for the diagnosis of gastroesophageal reflux esophagitis: “presentation of 100 cases”. Hepatogastroenterology 47: 174–180PubMedGoogle Scholar
  17. [17]
    Bate CM, Griffin SM, Keeling PW et al (1996) Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis. Aliment Pharmacol Ther 10: 547–555PubMedCrossRefGoogle Scholar
  18. [18]
    Shi G, Bruley des Varannes S, Scarpignato C et al (1995) Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 37: 457–464PubMedGoogle Scholar
  19. [19]
    Wiener GJ, Morgan TM, Copper JB et al (1988) Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 33: 1127–1133PubMedCrossRefGoogle Scholar
  20. [20]
    Vigneri S, Termini R, Leandro G et al (1995) A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 333: 1106–1110PubMedCrossRefGoogle Scholar
  21. [21]
    Castell DO, Kahrilas PJ, Richter JE et al (2002) Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol 97: 575–583PubMedCrossRefGoogle Scholar
  22. [22]
    Kuster E, Ros E, Toledo-Pimentel V et al (1994) Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow up of 107 patients. Gut 35: 8–14PubMedGoogle Scholar
  23. [23]
    McDougall NI, Johnston BT, Collins JS et al (1998) Three-to 4.5-year prospective study of prognostic indicators in gastro-oesophageal reflux disease. Scand J Gastroenterol 33: 1016–1022PubMedCrossRefGoogle Scholar
  24. [24]
    Pilotto A, Franceschi M, Leandro G et al (2002) Long-term clinical outcome of elderly patients with reflux esophagitis: a six-month to three-year follow-up study. Am J Ther 9: 295–300PubMedCrossRefGoogle Scholar
  25. [25]
    Fass R, Ofman JJ (2002) Gastroesophageal reflux disease — should we adopt a new conceptual framework? Am J Gastroenterol 97: 1901–1909PubMedGoogle Scholar
  26. [26]
    Sharma P, McQuaid K, Dent J et al (2004) A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop. Gastroenterology 127: 310–330PubMedCrossRefGoogle Scholar
  27. [27]
    Dresner SM, Griffin SM, Wayman J et al (2003) Human model of duodenogastro-oesophageal reflux in the development of Barrett’s metaplasia. Br J Surg 90: 1120–1128PubMedCrossRefGoogle Scholar
  28. [28]
    Martinez SDMI, Fass R (2001) Non-erosive reflux disease (NERD)-is it really just a mild form of gastroesophageal disease (GERD). Gastroenterology 120(Suppl 1)Google Scholar
  29. [29]
    Fass R, Hell RW, Garewal HS et al (2001) Correlation of oesophageal acid exposure with Barrett’s oesophagus length. Gut 48: 310–313PubMedCrossRefGoogle Scholar
  30. [30]
    Tharalson EF, Martinez SD, Garewal HS et al (2002) Relationship between rate of change in acid exposure along the esophagus and length of Barrett’s epithelium. Am J Gastroenterol 97: 851–856PubMedCrossRefGoogle Scholar
  31. [31]
    Iascone C, DeMeester TR, Little AG et al (1983) Barrett’s esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg 118: 543–549PubMedGoogle Scholar
  32. [32]
    Attwood SE, DeMeester TR, Bremner CG et al (1989) Alkaline gastroesophageal reflux: implications in the development of complications in Barrett’s columnar-lined lower esophagus. Surgery 106: 764–770PubMedGoogle Scholar
  33. [33]
    Fiorucci S, Santucci L, Farroni F et al (1989) Effect of omeprazole on gastroesophageal reflux in Barrett’s esophagus. Am J Gastroenterol 84: 1263–1267PubMedGoogle Scholar
  34. [34]
    Champion G, Richter JE, Vaezi MF et al (1994) Duodenogastroesophageal reflux: relationship to pH and importance in Barrett’s esophagus. Gastroenterology 107: 747–754PubMedGoogle Scholar
  35. [35]
    Robertson D, Aldersley M, Shepherd H et al (1987) Patterns of acid reflux in complicated oesophagitis. Gut 28: 1484–1488PubMedGoogle Scholar
  36. [36]
    Gillen P, Keeling P, Byrne PJ et al (1987) Barrett’s oesophagus: pH profile. Br J Surg 74: 774–776PubMedGoogle Scholar
  37. [37]
    Stein HJ, Barlow AP, DeMeester TR et al (1992) Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg 216: 35–43PubMedGoogle Scholar
  38. [38]
    Nandurkar S, Talley NJ (1999) Barrett’s esophagus: the long and the short of it. Am J Gastroenterol 94: 30–40PubMedCrossRefGoogle Scholar
  39. [39]
    Sharma P, Morales TG, Sampliner RE (1998) Short segment Barrett’s esophagus — the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol 93: 1033–1036PubMedGoogle Scholar
  40. [40]
    Sharma P, Sampliner RE (1998) Short segment Barrett’s esophagus and intestinal metaplasia of the cardia — it’s not all symantics! Am J Gastroenterol 93: 2303–2304PubMedGoogle Scholar
  41. [41]
    Spechler SJ (1997) Short and ultrashort Barrett’s esophagus — what does it mean? Semin Gastrointest Dis 8: 59–67PubMedGoogle Scholar
  42. [42]
    Loughney T, Maydonovitch CL, Wong RK (1998) Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett’s esophagus. Am J Gastroenterol 93: 916–919PubMedGoogle Scholar
  43. [43]
    Gerson LB, Shetler K, Triadafilopoulos G (2002) Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterology 123: 461–467PubMedCrossRefGoogle Scholar
  44. [44]
    Canto MI, Setrakian S, Petras RE et al (1996) Methylene blue selectively stains intestinal metaplasia in Barrett’s esophagus. Gastrointest Endosc 44: 1–7PubMedCrossRefGoogle Scholar
  45. [45]
    Sharma P, Topalovski M, Mayo MS et al (2001) Methylene blue chromoendoscopy for detection of short-segment Barrett’s esophagus. Gastrointest Endosc 54: 289–293PubMedCrossRefGoogle Scholar
  46. [46]
    Kouklakis GS, Kountouras J, Dokas SM et al (2003) Methylene blue chromoendoscopy for the detection of Barrett’s esophagus in a Greek cohort. Endoscopy 35: 383–387PubMedCrossRefGoogle Scholar
  47. [47]
    Wo JM, Ray MB, Mayfield-Stokes S et al (2001) Comparison of methylene blue-directed biopsies and conventional biopsies in the detection of intestinal metaplasia and dysplasia in Barrett’s esophagus: a preliminary study. Gastrointest Endosc 54: 294–301PubMedCrossRefGoogle Scholar
  48. [48]
    Yagi K, Nakamura A, Sekine A (2003) Accuracy of magnifying endoscopy with methylene blue in the diagnosis of specialized intestinal metaplasia and short-segment Barrett’s esophagus in Japanese patients without Helicobacter pylori infection. Gastrointest Endosc 58: 189–195PubMedCrossRefGoogle Scholar
  49. [49]
    Sharma P, Weston AP, Topalovski M et al (2003) Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett’s oesophagus. Gut 52: 24–27PubMedCrossRefGoogle Scholar
  50. [50]
    Ismail-Beigi F, Horton PF, Pope CE, 2nd (1970) Histological consequences of gastroesophageal reflux in man. Gastroenterology 58: 163–174PubMedGoogle Scholar
  51. [51]
    Ismail-Beigi F, Pope CE, 2nd (1974) Distribution of the histological changes of gastroesophageal reflux in the distal esophagus of man. Gastroenterology 66: 1109–1113PubMedGoogle Scholar
  52. [52]
    Belafsky PC, Postma GN, Koufman JA et al (2002) Stevens-Johnson syndrome with diffuse esophageal involvement. Ear Nose Throat J 81: 220PubMedGoogle Scholar
  53. [53]
    Steiner SJ, Gupta SK, Croffie JM et al (2004) Correlation between number of eosinophils and reflux index on same day esophageal biopsy and 24-hour esophageal pH-monitoring. Am J Gastroenterol 99: 801–805PubMedCrossRefGoogle Scholar
  54. [54]
    Johnson LF, Demeester TR, Haggitt RC (1978) Esophageal epithelial response to gastroesophageal reflux. A quantitative study. Am J Dig Dis 23: 498–509PubMedCrossRefGoogle Scholar
  55. [55]
    Schindlbeck NE, Wiebecke B, Klauser AG et al (1996) Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease. Gut 39: 151–154PubMedGoogle Scholar
  56. [56]
    Bowrey DJ, Williams GT, Clark GW (2003) Histological changes in the oesophageal squamous mucosa: correlation with ambulatory 24-hour pH-monitoring. J Clin Pathol 56: 205–208PubMedCrossRefGoogle Scholar
  57. [57]
    M. Veith UP, Labenz J (2004) What parameters are relevant for the histological diagnosis of Gastroesophageal reflux disease without Barrett’s mucosa? Dig Dis 22: 196–201CrossRefGoogle Scholar
  58. [58]
    Carlo Calabrese AF, Mauro Bortolotti (2003) Comparative results of esophageal damage in GERD and DGER: dilation of intercellular spaces as a marker of esophageal injury [abstract]. GastroGoogle Scholar
  59. [59]
    Tam WCE DJ, Conroy-Hiller TA (2001) Proposed new Endoscopic criteria for minimal change reflux esophagitis based on magnification endoscopy [abstract]. Gastrointes Endosc 53: AB119Google Scholar
  60. [60]
    Tam WEA, Bruno M (2002) Endoscopy-negative reflux disease: high-resolution endoscopic and histological signs [abstract]. Gastro 122: A74Google Scholar
  61. [61]
    Kiesslich R, Kanzler S, Vieth M et al (2004) Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopy. Dig Dis 22: 221–227PubMedCrossRefGoogle Scholar
  62. [62]
    Liacouras CA, Markowitz JE (1999) Eosinophilic esophagitis: a subset of eosinophilic gastroenteritis. Curr Gastroenterol Rep 1: 253–258PubMedGoogle Scholar
  63. [63]
    Wiklund I, Glise H, Jerndal P et al (1998) Does endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc 47: 449–454PubMedCrossRefGoogle Scholar
  64. [64]
    Sampliner RE, Garewal HS, Fennerty MB et al (1990) Lack of impact of therapy on extent of Barrett’s esophagus in 67 patients. Dig Dis Sci 35: 93–96PubMedCrossRefGoogle Scholar
  65. [65]
    Szarka LA, DeVault KR, Murray JA (2001) Diagnosing gastroesophageal reflux disease. Mayo Clin Proc 76: 97–101PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2006

Authors and Affiliations

  • A. Bansal
    • 1
  • P. Sharma
    • 1
  1. 1.School of Medicine and Veteran Affairs Medical CenterUniversity of KansasKansas CityUSA

Personalised recommendations